Wednesday, July 8, 2026

pharma · Parkinson Disease · Tuberculosis · GANX

Gain Therapeutics

Gain Therapeutics is a pharma organization headquartered in Bethesda, USA. It trades on NYSE under ticker GANX. Primary therapeutic focus areas include Parkinson Disease, Tuberculosis, Long-term Care Centres for Old Adul

Bethesda, USA HQ
2017 Founded
28 Employees
Public company Type
GANX · NYSE Ticker
Company details
Status
Public
HQ
Bethesda, USA
Founded
2017
Employees
28
Programs
4
Drugs
7
Patents
27
Clinical program

Envita Stories Methodology in Long-term care Centres for old adults

Unknown · other · Long-term Care Centres for Old Adults Users

Envita Stories Methodology in Long-term care Centres for old adults for Long-term Care Centres for Old Adults Users is a Unknown program (other) at Gain Therapeutics with 1 ClinicalTrials.gov record(s).

Internal code 03_IN606D_2023_ 2529780

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Gain Therapeutics
Phase
Unknown
Modality
other
Indication
Long-term Care Centres for Old Adults Users
Status
active
Trials
1